Holen Sie sich die Stockscreener-App
2.94
2.44%
0.07
Handel nachbörslich:
2.94
Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
70.00 | - | - | - |
Operating Expenses
|
13.25%
13.42
|
15.47 | 18.27 | 18.13 | 22.13 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
13.25%
13.42
|
15.47 | - | - | - |
| Operating Income/Loss |
124.61%
-13.42
|
54.53 | -18.27 | -18.13 | -22.13 |
| Nonoperating Income/Loss |
42.10%
2.859
|
2.012 | 2.29 | 2.573 | 2.221 |
| Income/Loss From Continuing Operations Before Tax |
118.68%
-10.56
|
56.54 | -15.98 | -15.56 | -19.91 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.226 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
118.68%
-10.56
|
56.54 | -15.98 | -15.56 | -19.91 |
|
Net Income/Loss
|
118.68%
-10.56
|
56.54 | -15.98 | -15.56 | -19.91 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.25%
56.80
|
56.66 | 0.5303 | 56.51 | 55.16 |
| Diluted Average Shares |
1.51%
56.80
|
57.67 | 0.5303 | 56.51 | 55.16 |
| Basic Earnings Per Share |
119.00%
-0.19
|
1.00 | -0.28 | -0.28 | -0.36 |
| Diluted Earnings Per Share |
119.39%
-0.19
|
0.98 | -0.28 | -0.28 | -0.36 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):